We are live on ! Find out more
NAM

Needelman Asset Management Portfolio holdings

AUM $46M
1-Year Est. Return 8.27%
This Fund
S&P 500
This Quarter Est. Return
+4.45%
1 Year Est. Return
+8.27%
3 Year Est. Return
+30.52%
5 Year Est. Return
+74.86%
10 Year Est. Return
AUM
$36.1M
AUM Growth
+$2.79M
Cap. Flow
+$1.77M
Cap. Flow %
4.9%
Top 10 Hldgs %
36.57%
Holding
37
New
1
Increased
10
Reduced
24
Closed

Top Buys

Rank Stock Value
1
KHC icon
Kraft Heinz
KHC
+$376K
2
CB icon
Chubb
CB
+$336K
3
ABT icon
Abbott
ABT
+$329K
4
YUMC icon
Yum China
YUMC
+$310K
5
GE icon
GE Aerospace
GE
+$290K

Top Sells

Rank Stock Value
1
YUM icon
Yum! Brands
YUM
+$280K
2
CMG icon
Chipotle Mexican Grill
CMG
+$47.3K
3
TEVA icon
Teva Pharmaceuticals
TEVA
+$44.7K
4
UNH icon
UnitedHealth
UNH
+$29.9K
5
HON icon
Honeywell
HON
+$16.8K

Sector Composition

Rank Sector Weight
1 Healthcare 24.71%
2 Financials 22.89%
3 Technology 12.86%
4 Consumer Staples 12.4%
5 Industrials 11.97%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BAC icon
1
Bank of America
BAC
$435B
$1.59M 4.41%
72,096
-610
-0.8% -$11.7K
UNH icon
2
UnitedHealth
UNH
$376B
$1.51M 4.19%
9,450
-200
-2% -$29.9K
JPM icon
3
JPMorgan Chase
JPM
$935B
$1.38M 3.82%
15,958
-80
-0.5% -$6.1K
MSFT icon
4
Microsoft
MSFT
$3.45T
$1.37M 3.79%
21,990
-240
-1% -$14.4K
ELV icon
5
Elevance Health
ELV
$81.5B
$1.33M 3.69%
9,275
-95
-1% -$12.7K
BRK.B icon
6
Berkshire Hathaway Class B
BRK.B
$1.1T
$1.27M 3.53%
7,820
-75
-0.9% -$11.5K
MKL icon
7
Markel Group
MKL
$23.3B
$1.24M 3.42%
1,365
-10
-0.7% -$8.92K
INTC icon
8
Intel
INTC
$455B
$1.19M 3.29%
32,720
-460
-1% -$16.5K
HON icon
9
Honeywell
HON
$77B
$1.17M 3.23%
11,132
-165
-1% -$16.8K
GE icon
10
GE Aerospace
GE
$374B
$1.15M 3.19%
7,604
+1,997
+36% +$290K
JNJ icon
11
Johnson & Johnson
JNJ
$618B
$1.15M 3.18%
9,970
-55
-0.5% -$6.35K
CVX icon
12
Chevron
CVX
$392B
$1.15M 3.17%
9,730
+1,285
+15% +$140K
QCOM icon
13
Qualcomm
QCOM
$155B
$1.1M 3.04%
16,845
-80
-0.5% -$5.38K
CB icon
14
Chubb
CB
$135B
$1.08M 3%
8,206
+2,637
+47% +$336K
ABT icon
15
Abbott
ABT
$183B
$1.03M 2.86%
26,832
+8,285
+45% +$329K
FLR icon
16
Fluor
FLR
$7.01B
$1.02M 2.84%
19,480
+2,695
+16% +$140K
PFE icon
17
Pfizer
PFE
$143B
$997K 2.76%
32,358
-68
-0.2% -$2.08K
EMR icon
18
Emerson Electric
EMR
$83.9B
$979K 2.71%
17,555
+290
+2% +$15.6K
DEO icon
19
Diageo
DEO
$49B
$963K 2.67%
9,262
+2,285
+33% +$240K
PG icon
20
Procter & Gamble
PG
$336B
$956K 2.65%
11,370
-20
-0.2% -$1.71K
T icon
21
AT&T
T
$159B
$951K 2.64%
29,618
+4,581
+18% +$135K
AON icon
22
Aon
AON
$76.5B
$932K 2.58%
8,360
-15
-0.2% -$1.67K
KHC icon
23
Kraft Heinz
KHC
$30.7B
$923K 2.56%
10,576
+4,394
+71% +$376K
KMB icon
24
Kimberly-Clark
KMB
$36.3B
$875K 2.42%
7,663
-50
-0.6% -$5.8K
BMY icon
25
Bristol-Myers Squibb
BMY
$133B
$865K 2.4%
14,800
-30
-0.2% -$1.64K

Similar funds

Needelman Asset Management's Q4 2016 Portfolio in Review

As of Q4 2016, Needelman Asset Management held 37 positions worth $36.1M, up 8.4% from $33.3M the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Needelman Asset Management deployed $1.77M of net new capital in Q4 2016, opening 1 new position and adding to 10 existing holdings. Its largest new stake was Yum China: 11,400 shares worth $298K.

By sector, the portfolio is most concentrated in Healthcare at 25% of assets, down from 26% a quarter earlier, followed by Financials and Technology.

On the sell side, the largest reduction was Yum! Brands, an estimated $280K trimmed.

  • Needelman Asset Management's largest Q4 2016 buy was Yum China: 11,400 shares worth $298K.
  • Needelman Asset Management added most to Kraft Heinz in Q4 2016, an estimated $376K increase.
  • Needelman Asset Management's biggest Q4 2016 reduction was Yum! Brands, cutting an estimated $280K.
  • Needelman Asset Management's ten largest holdings make up 37% of its $36.1M portfolio in Q4 2016.
  • Needelman Asset Management opened 1 new position and closed 0 in Q4 2016.
  • Needelman Asset Management's portfolio value rose 8.4% quarter-over-quarter to $36.1M.

Based on Needelman Asset Management's 13F filing for Q4 2016, filed 6 Jan 2017.